Editions:  Austria · Denmark · France · Germany · Italy · Norway · Spain · Sweden · Switzerland
Advertisement

Children's lives at risk from fake medicine

Share this article

Children's lives at risk from fake medicine
The counterfeit medicine could risk lives. Photo: Pranjal Mahna/Flickr
14:44 CEST+02:00
Three directors of an Italian pharmaceutical company have been arrested for allegedly counterfeiting respiratory medicine, putting babies and children at risk, the Italian Medicines Agency (AIFA) said today.

The trio work for Italian pharmaceuticals company Geymonat and are accused of faking and marketing the Ozopulmin drug across Italy.

 

“The drug has been deliberately counterfeited and is therefore dangerous to the health of babies and children,” AIFA said.

 

However, the AIFA stressed that batches of affected drugs were removed from the market at the start of the investigation.

 

The accused were arrested this morning in Latina, south of Rome, following a six-month investigation by AIFA and officers from NAS, a branch of the police force specializing in health.

 

The fake drugs could lead to a worsening of a patient’s respiratory condition, AIFA added.

Get notified about breaking news on The Local

Share this article

Advertisement
Advertisement
Advertisement
Jobs
Click here to start your job search
Advertisement
Advertisement

Popular articles

Advertisement
Advertisement